NEW CASE STUDIES: SEE HOW NUSHIELD® HELPED TO SUPPORT WOUND MANAGEMENT

More hyaluronic acid, and thickness

Compared to another commercially available dehydrated human amnion/chorion membrane to support use as a protective barrier (dHACM)1

NuShield contains, on average, over 6x more hyaluronic acid for use as a protective barrier1

Note: * indicates significance where P<0.05

In this evaluation, HA levels were significantly higher in NuShield to support use as a protective barrier than in another commercially available dHACM, with an average of 3.25 μg/cm2 HA in NuShield compared to 0.52 μg/cm2 HA in the other commercially available dHACM.1

NuShield provides more thickness to support use as a protective barrier due to the retention of the spongy layer

An evaluation of graft structure found that the preservation method used by another commercially available dHACM removes most of the spongy layer, making it, on average, thinner than NuShield.1

NuShield

Another commercially available dHACM

Histological assessment with immunohistochemistry for hematoxylin and eosin. hyaluronic acid. Each stain shows a representative image taken with a 20x objective for each donor.1

Find comprehensive support with NuShield

View our provider support, or talk to an Organogenesis Tissue Regeneration Specialist about supporting your practice with the more complete dehydrated placental allograft tissue product.

Contact us

Please refer to the NuShield instructions for use for usage and safety information.

REFERENCES:

  1. Data on file. DR-0004-2018-07-03. Organogenesis Inc.